TrianglePUBLICATIONS · 22949147
Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2012 Oct 1
- First author
- Van Cutsem E
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Van Cutsem E
- type
- Author
- name
- Tabernero J
- type
- Author
- name
- Lakomy R
- type
- Author
- name
- Prenen H
- type
- Author
- name
- Prausová J
- type
- Author
- name
- Macarulla T
- type
- Author
- name
- Ruff P
- type
- Author
- name
- van Hazel GA
- type
- Author
- name
- Moiseyenko V
- type
- Author
- name
- Ferry D
- type
- Author
- name
- McKendrick J
- type
- Author
- name
- Polikoff J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Van Cutsem E
- type
- Author
- name
- Tabernero J
- type
- Author
- name
- Lakomy R
- type
- Author
- name
- Prenen H
- type
- Author
- name
- Prausová J
- type
- Author
- name
- Macarulla T
- type
- Author
- name
- Ruff P
- type
- Author
- name
- van Hazel GA
- type
- Author
- name
- Moiseyenko V
- type
- Author
- name
- Ferry D
- type
- Author
- name
- McKendrick J
- type
- Author
- name
- Polikoff J
- type
- Author
- bibliography ids
- nci-bib-0a49c4151965dba6db3c2564
- book metadata
- content sha256
- 6f755989bfb016e49d16a2c8feb803c517f24c289159b7d0d341e9a57aa42141
- document type
- citation
- dois
- 10.1200/JCO.2012.42.8201
- electronic publication date
- display
- 2012 Sep 4
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22949147
- immutable id
- pubmed:22949147@6f755989bfb016e49d16a2c8feb803c517f24c289159b7d0d341e9a57aa42141
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 28
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3499-506
- volume
- 30
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22949147
- provenance
- batch id
- 1e3045de9f47a5ccd566
- provider
- NCBI PubMed ESummary
- record sha256
- 5eeccb6a58c25556caff02b92fe9774907e36aa1564a5bf4fa12a92af3d0d705
- response sha256
- 0c42e87ee821aef9d804e2d77dfdba8876f375111db163986dd22ba43a3d6a52
- retrieved at
- 2026-09-09T23:46:50.128287+00:00
- publication date
- display
- 2012 Oct 1
- precision
- day
- year
- 2012
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.
Preserved source evidence · Independent clinical review pending · Not medical advice